Covestor’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Sell |
1,418
-293
| -17% | -$10.7K | 0.03% | 881 |
|
|
2025
Q1 | $62K | Buy |
1,711
+795
| +87% | +$28.8K | 0.04% | 754 |
|
|
2024
Q4 | $39K | Buy |
916
+225
| +33% | +$9.58K | 0.02% | 944 |
|
|
2024
Q3 | $38K | Buy |
691
+2
| +0.3% | +$110 | 0.02% | 970 |
|
|
2024
Q2 | $28K | Sell |
689
-306
| -31% | -$12.4K | 0.02% | 1072 |
|
|
2024
Q1 | $46K | Sell |
995
-216
| -18% | -$9.99K | 0.03% | 921 |
|
|
2023
Q4 | $58K | Buy |
1,211
+463
| +62% | +$22.2K | 0.04% | 781 |
|
|
2023
Q3 | $27K | Buy |
748
+596
| +392% | +$21.5K | 0.02% | 1015 |
|
|
2023
Q2 | $7K | Buy |
152
+22
| +17% | +$1.01K | 0.01% | 1641 |
|
|
2023
Q1 | $5K | Buy |
130
+1
| +0.8% | +$38 | ﹤0.01% | 1573 |
|
|
2022
Q4 | $6K | Sell |
129
-40
| -24% | -$1.86K | ﹤0.01% | 1534 |
|
|
2022
Q3 | $7K | Buy |
169
+45
| +36% | +$1.86K | 0.01% | 1409 |
|
|
2022
Q2 | $7K | Sell |
124
-1
| -0.8% | -$56 | 0.01% | 1317 |
|
|
2022
Q1 | $9K | Buy |
125
+54
| +76% | +$3.89K | 0.01% | 1355 |
|
|
2021
Q4 | $6K | Buy |
+71
| New | +$6K | 0.01% | 1249 |
|